战略与国际研究中心-Strengthening-US_32页_383kb

Summary of Strengthening U.S.-French Collaboration on HIV/AIDS in Africa

Core Content

This report summarizes a conference hosted by the Center for Strategic and International Studies (CSIS) and the Brookings Institution in December 2001, focusing on enhancing U.S.-French collaboration in the fight against HIV/AIDS in Africa. The conference aimed to identify new opportunities for joint action and to highlight the critical role of African participation in addressing the crisis.

Main Points and Key Information

1. HIV/AIDS as a Global and Regional Priority

• Importance in Foreign Policy: HIV/AIDS has become a central issue in U.S. and French foreign policy, especially after September 11, where it was one of the few issues that remained prominent in the public eye alongside terrorism.
• Impact on Africa: Africa is the most affected region, with 25 million deaths reported by UNAIDS, and the disease is now the fourth-largest killer globally. It disproportionately affects sub-Saharan Africa, where 3 million people died from AIDS in 2001 alone.
• Stability Concerns: HIV/AIDS threatens political stability, economic development, and social structures. It is linked to increased poverty, family breakdown, and the loss of human capital, particularly among young adults (15-49 years), who are the most productive.

2. Role of the Global Fund

• Establishment and Funding: The Global Fund to Fight AIDS, TB, and Malaria was established in 2001 and is expected to be operational by early 2002. By the end of 2001, $1.7 billion had been committed to the fund.
• U.S. and French Involvement: The U.S. government, under President Bush, pledged $200 million to the Global Fund, while France committed 150 million euros over three years. Both countries support a coordinated global approach.
• Collaboration Needs: There is a need for U.S.-French cooperation in shaping the Global Fund's procedures and programs, ensuring equitable access to essential medicines and fostering a flexible, comprehensive strategy.

3. Bilateral and Multilateral Collaboration

• Encouraging African Leadership: Both the U.S. and France should support African ownership of HIV/AIDS initiatives, encouraging local leaders to take a catalytic role in combating the pandemic.
• Coordinating Donor Efforts: Closer collaboration between donor governments is necessary to ensure complementarity and leverage comparative advantages. The EU and U.S. could work together to reduce the cost of antiretrovirals.
• Institutional Arrangements: Memoranda of agreement and information-sharing among implementing agencies are recommended to improve coordination and effectiveness.

4. Programmatic and Research Collaboration

• "Hospital-Twinning" Model: France has proposed a "hospital-twinning" initiative to strengthen African health systems and improve access to treatment. The U.S. could adopt a similar approach.
• Joint Research and Trials: U.S. and French institutions, including the NIH, ANRS, and Institut Pasteur, are collaborating on vaccine research. There is a need for joint studies and more exchanges between researchers.
• Military and Peacekeeping Role: Military personnel, especially in Africa, are at high risk of contracting HIV/AIDS. The U.S. should develop military-to-military training programs on health, modeled after the IMET human rights program. The French military has a stronger presence in this area.

5. Potential Venues for Collaboration

• Target Countries: Côte d'Ivoire, Senegal, South Africa, and Kenya are suggested as potential venues for enhanced U.S.-French collaboration.
• Regional Organizations: SADC and COMESA could serve as platforms for cooperation.
• Haiti as a Candidate: Although not in Africa, Haiti is a priority for U.S.-French collaboration due to its acute HIV/AIDS crisis and weak health infrastructure. French hospitals have already volunteered to participate in the "hospital-twinning" scheme.

6. Challenges and Recommendations

• Cultural and Institutional Differences: U.S. and French approaches to HIV/AIDS differ, with the U.S. focusing more on prevention and France emphasizing access to care and treatment.
• Need for Leadership and Commitment: Both countries must lead and collaborate more effectively, moving beyond competition to create a unified strategy.
• Future Steps: CSIS will continue to explore areas of potential collaboration, including operationalizing "twinning" projects, engaging the corporate sector, and improving access to essential medicines.

Conclusion

The conference highlighted the urgent need for U.S.-French collaboration in addressing the HIV/AIDS crisis in Africa. It emphasized the importance of African participation, institutional coordination, and joint efforts in research, treatment, and prevention. The establishment and success of the Global Fund depend on strong bilateral cooperation and a comprehensive, integrated approach to the disease.